NIACINAMIDE 4% / CLOBETASOL PROPIONATE 0.05%
- Manufacturer
- Sincerus Florida, LLC
- Effective date
- 2019-05-20
- Label type
- HUMAN PRESCRIPTION DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 20:28:53
Label at a glance#
ProductNIACINAMIDE 4% / CLOBETASOL PROPIONATE 0.05%
Active ingredientCLOBETASOL PROPIONATE, NIACINAMIDE
Label structure4 sections
Label contents#
Full prescribing information#
Sincerus Florida, LLC. Adverse reactions
Active, inactive
NDC 72934- 4154-5 NIACINAMIDE USP 4% / CLOBETASOL PROPIONATE USP 0.05%. Solution 60 gm.
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| CLOBETASOL Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 20abe2c3-3e80-d2b2-39eb-3156e4af4799 | Product name | 3 | 20250124 |
| 45ad92f8-d116-4c0c-851c-2e740b7d8e6f | Product name | 1 | 20250122 |
| 42be0ad5-6fd7-4f1b-8108-6d9dd7d571df | Product name | 7 | 20250107 |
| 3813b789-94b9-edd6-f010-6b926dd462e5 | Product name | 5 | 20230113 |
| 30eee8a1-850e-41ed-b5ab-761301aeab49 | Product name | 6 | 20221206 |
| 18e5b6f7-c414-b1f1-b684-17fdd02c215e | Product name | 4 | 20210927 |
| 1c87bbde-dd91-a122-db33-67ae814cb645 | Product name | 7 | 20210510 |
| 519b5875-7d7d-4aa6-9d3d-470fa1376595 | Product name | 4 | 20200227 |
| 98669154-3e9c-47da-8a2c-656ab71848be | Product name | 2 | 20180607 |
| 8d4f8539-436f-453b-8b76-5322d403fc8e | Product name | 1 | 20180131 |
| 837ac3c6-ee71-c5a6-6eba-c4065f37e9f5 | Product name | 2 | 20171010 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 72934-4154-5 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-3ab0-a910-e053-dadaa90a0b85 | NIACINAMIDE 4% / CLOBETASOL PROPIONATE 0.05% |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72934-4154-5 | NIACINAMIDE 4% / CLOBETASOL PROPIONATE 0.05% | 60 g in 1 CYLINDER | SOLUTION | 60 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 72934-4154 | NIACINAMIDE 4% / CLOBETASOL PROPIONATE 0.05% SOLUTION [SINCERUS FLORIDA, LLC] | 1 | Legacy NDC, 1 package rows | 20190521_8958565f-7d52-c7a2-e053-2a95a90a77ab.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72934-4154-5 | GM - Gram | 72934-4154 | bab09135-914c-4a5c-a39f-2ce8e780c8ae | 1 | 2020-03-10 |
Products#
Every source-derived product name is available through these pages.
- NIACINAMIDE 4% / CLOBETASOL PROPIONATE 0.05%
- CLOBETASOL PROPIONATE
- CLOBETASOL
- NIACINAMIDE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 72934-4154 | 72934-4154-5 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CLOBETASOL PROPIONATE | 779619577M | ACTIB |
| NIACINAMIDE | 25X51I8RD4 | ACTIB |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 8958565f-7d53-c7a2-e053-2a95a90a77ab | 8958565f-7d52-c7a2-e053-2a95a90a77ab | 2019-05-20 | Adverse reactions | 8958565f-7d53-c7a2-e053-2a95a90a77ab 8958565f-7d52-c7a2-e053-2a95a90a77ab |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.


